Teladoc Health (Teladoc Health) ROCE % : -2.01% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Teladoc Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Teladoc Health's annualized ROCE % for the quarter that ended in Dec. 2023 was -2.01%.

Teladoc Health ROCE % Historical Data

The historical data trend for Teladoc Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teladoc Health ROCE % Chart

Teladoc Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-5.38

-5.45

-1.74

-127.79

-4.98

Teladoc Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-261.71	-6.41	-6.14	-5.49	-2.01

Teladoc Health ROCE % Calculation

Teladoc Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-197.326	/	( ( (4345.355 - 399.769)	+	(4392.369 - 420.616) )	/ 2 )
	=	-197.326	/	( (3945.586	+	3971.753)	/ 2 )
	=	-197.326	/	3958.6695
	=	-4.98 %

Teladoc Health's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-79.348	/	( ( (4327.973 - 402.64)	+	(4392.369 - 420.616) )	/ 2 )
	=	-79.348	/	( ( 3925.333	+	3971.753 )	/ 2 )
	=	-79.348	/	3948.543
	=	-2.01 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Teladoc Health (NYSE:TDOC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Teladoc Health ROCE % Related Terms

Thank you for viewing the detailed overview of Teladoc Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Teladoc Health (Teladoc Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Teladoc Health Inc (NYSE:TDOC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

TDOC:Mexico 4LL:Germany T2DH34:Brazil

Address

2 Manhattanville Road, Suite 203, Purchase, NY, USA, 10577

Website

https://www.teladochealth.com

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.

Executives

Daniel Trencher	officer: SVP Corporate Strategy	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Vidya Raman-tangella	officer: Chief Medical Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Karen L Daniel	director	2801 80TH STREET, KENOSHA WI 53141
Jason N Gorevic	director, officer: President & CEO
Andrew Turitz	officer: SVP - Business Development	C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Stephany Verstraete	officer: Chief Marketing Officer	C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Adam C Vandervoort	officer: Chief Legal Officer, Secretary	485 MADISON AVENUE, NEW YORK NY 10022
Mala Murthy	officer: Chief Financial Officer	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Richard J Napolitano	officer: Chief Accounting Officer	MSCI INC., 7 WORLD TRADE CENTER, 250 GREENWICH STREET, 49TH FLOOR, NEW YORK NY 10007
Arnnon Geshuri	officer: Chief Human Resources Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Laizer Kornwasser	officer: PRESIDENT, ENTERPRISE GROWTH	100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Michael Willem Waters	officer: CHIEF OPERATING OFFICER	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Jason Eric Evans	director	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Claus Torp Jensen	officer: Chief Innovation Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Sandra L Fenwick	director	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577